Leading Liver Disease Researchers Present at EASL International Liver Congress 2021, Demonstrate Prognostic Value of Echosens FibroScan-based Agile Scores for Patients with Liver Disease finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Echosens Launches New FibroScan-Based Scores Agile 3+ & Agile 4: Identifies Advanced Fibrosis and Cirrhosis, Predicts Clinical Outcomes, Improves Patient Management Echosens, a high-technology company offering the FibroScan family of products, today announces the global launch of FibroScan-based Agile scores to easily detect advanced fibrosis and cirrhosis in non-alcoholic fatty liver disease (NAFLD) patients, reduce the number of false positive cases compared to liver stiffness measurement by vibration controlled transient elastography (LSM by VCTE) alone, accurately predict liver complications and, in coming years, identify patients eligible for pharmaceutical treatments.
Learn more about myFibroScan here. Agile scores deliver a new level of value to the FibroScan solution by enhancing capabilities in the management of non-alcoholic fatty liver patients, improving early identification of those who are at risk and helping providers initiate the right intervention, says